These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14199849)

  • 21. [Our experience with the use of biloptin and bilivistan in the study of the biliary tract].
    Bini F; Bocchi R
    Ann Radiol Diagn (Bologna); 1970; 43(1):56-69. PubMed ID: 5496469
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intravenous cholangiocholecystography with Bilivistan. Clinico-radiological findings].
    Crespi Porro R; Borghi A; Caresano A
    Quad Radiol; 1967; 32(1):91-105. PubMed ID: 5600354
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative evaluation of cholecystography, cholangiography, echotomography and cholescintigraphy in surgical disorders of the bile ducts].
    Sgro M; Murè G; Campanoni V; Clerici R
    Minerva Med; 1982 Jan; 73(3-4):109-14. PubMed ID: 7058009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ioglycamide acid (Bilivistan) low-dose drip-infusion cholangiography.
    Fork FT; Ekberg O
    Br J Radiol; 1980 Aug; 53(632):770-3. PubMed ID: 7437687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined cholangiography and cholecystography using sodium iopanoate.
    Koehler RE; Goldberg HI
    Invest Radiol; 1977; 12(3):267-72. PubMed ID: 863631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dose-effects of the contrast medium Iotroxinate on biliary excretion of contrast media during infusion cholegraphy (author's transl)].
    Klapdor R
    Rofo; 1978 Aug; 129(2):215-6. PubMed ID: 151018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholangio-cholecystography using Bilivistan, a new transvenous contrast medium].
    Shirakabe H; Ueno T; Ofuji M; Kohakuki S; Kuroda K
    Rinsho Hoshasen; 1966 Jan; 11(1):30-6. PubMed ID: 5181030
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative assessment of peroral, intravenous and infusion methods of investigating bile-excretory ducts].
    Aliev VM; Kushnarevich RL; Ilashev AI; Lisina MM; Khakimov AR
    Sov Med; 1972 Aug; 35(8):146-7. PubMed ID: 5070534
    [No Abstract]   [Full Text] [Related]  

  • 31. An oral cholecystographic method using telepaque with demonstration of the common and cystic ducts.
    GRUGAN RA
    Radiology; 1953 Oct; 61(4):633-6. PubMed ID: 13100674
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)].
    Sviridov NK; Popova ZP; Varfolomeeva VN; Mikhaĭlova NA
    Farmakol Toksikol; 1981; 44(2):245-7. PubMed ID: 7023971
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bilivistan in healthy persons and in liver patients].
    Thelen D
    Med Klin; 1967 Aug; 62(31):1194-8. PubMed ID: 5598242
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cholecystography and cholangiography. A statistical study].
    Klemm J; Dell M; Hahn W
    Med Klin; 1969 May; 64(21):981-4. PubMed ID: 5783932
    [No Abstract]   [Full Text] [Related]  

  • 35. [Initial results of a study of a new contrast media "per os" for the extrahepatic bile ducts].
    VOSSE-MATAGNE G; RUYTERS L; VAN MAERCKE Y; DEMEULENAERE L
    Acta Gastroenterol Belg; 1962 Oct; 25():794-803. PubMed ID: 13997959
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intramuscular cholangiocholecystography with Bilivistan. Clinico-radiological findings].
    Crespi Porro R; De Santis L; Caresano A
    Minerva Radiol; 1967 Oct; 12(10):351-8. PubMed ID: 5610513
    [No Abstract]   [Full Text] [Related]  

  • 37. The undesirability of post-choledochotomy cholangiography as an initial operative diagnostic procedure.
    Petereit MF
    S D J Med; 1973 Mar; 26(3):9-17. PubMed ID: 4512040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospects of using modern x-ray contrast substances for intravenous cholegraphy (a review of the literature)].
    Sviridov NK
    Vestn Rentgenol Radiol; 1981; (6):78-81. PubMed ID: 7036516
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of serum-binding capacity on the contrast media in the cholangiocystogram].
    Kölling K; Schoen D
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Sep; 113(3):372-5. PubMed ID: 5533871
    [No Abstract]   [Full Text] [Related]  

  • 40. Bilivistan--a new contrast medium for intravenous cholangiocystography. Preliminary report.
    Bell HD; Braband H
    Br J Radiol; 1966 Jan; 39(457):63-5. PubMed ID: 5902405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.